Agoracom Blog Home

Author Archive

PyroGenesis $PYR.ca Comments on Recent Trading Activity; Military, Tunneling, Drosrite, Pelletization, PUREVAP; All on Track $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 2:13 PM on Monday, August 24th, 2020
  • Company wishes to reassure investors that all projects (Military, Tunneling, Drosrite™, Pelletization, PUREVAP™, etc…) are all on track and there are no undisclosed events to warrant this morning’s decline.
  • Everything material has been disclosed by the Company in either its press releases or financial reports. PyroGenesis further confirms that none of the contracts press released are at risk.
  • Last but not least, the Company wishes to reassure PyroGenesis’ shareholders that we remain on track with our current and prospective projects.

MONTREAL, Aug. 24, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, issues this press release in response to this morning’s trading activity, and the sudden decline in its stock price. The Company wishes to reassure investors that all projects (Military, Tunneling, Drosrite™, Pelletization, PUREVAP™, etc…) are all on track and there are no undisclosed events to warrant this morning’s decline.

The Company does not usually opine on stock price and trading activity, however, given the recent decline, and inquiries from investors, the Company confirms the following:

Everything material has been disclosed by the Company in either its press releases or financial reports. PyroGenesis further confirms that none of the contracts press released are at risk. Last but not least, the Company wishes to reassure PyroGenesis’ shareholders that we remain on track with our current and prospective projects.

“I just wanted to take the time to reassure investors that the precipitous decline in stock price today cannot be explained by any undisclosed developments at the Company,” said Mr. P. Peter Pascali, CEO and President of PyroGenesis.  “To the contrary, all of our projects are moving ahead and are closer to completion than before. The potential contracts previously announced are not in jeopardy and are moving ahead. Regretfully, to those looking from the outside, it always seems to take longer than expected, however, nothing can be further from the truth and, in certain instances, are proceeding with lightning speed particularly given the entities we are talking to and the significance of the contracts under discussion.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development,
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The #Pharmaceutical Guided Missile To Defeat #Coronavirus Lung Infections $GWPH $CRDL.ca $TEVA

Posted by AGORACOM-JC at 1:54 PM on Monday, August 24th, 2020
Innocan-Blog

InnoCan – Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections 

InnoCan Pharma Is A Pharmaceutical Company That Specializes In The Development Of New Drug Platforms Which Combine Unique Properties of Cannabinoids

WHY INNOCAN?

InnoCan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

PHARMACEUTICAL – THE GUIDED MISSILE

  • Revolutionary Technology Targeting Lungs Infected  With Coronavirus or other viral infections 
    • Done By Combining CBD with Stem Cell Particles (Exosomes)
    • Research & Licensing Agreement with Tel Aviv University
  • Developing CLX, The ICBM Ballistic Missile Of Coronavirus Lung Infections
  • Separate breakthrough delivery and control release technology that enables the injection of CBD.

CONSUMER RETAIL – DERMA COSMETICS 

  • A Premium Derma Cosmetics Brand
  • Containing Highly Concentrated Ingredients Formulated with CBD
  • Manufacturing & Supply Agreements – Europe and United States
  • Manufacturing Has Commenced For 9 Products As Of Q2 2020
  • Distribution Agreements – United Kingdom and Ireland

Company entered into a distribution agreement (with a Swiss CBD provider called Cloud 9 Switzerland LLC  to sell the Company’s SHIRTM Beauty and Relief & Go product lines in Italy and Switzerland.

OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF

  • Patent-Pending CBD Pain Relief Brand
  • Versions Include Spray, Roll-On and Cream
  • Relief & Go Spray – First Product Being Manufactured
    • FDA Technical Validation
    • FDA Approval To Commence Marketing In The United States
  •   Manufacturing Commencement
    • New Jersey (United States Market)
    • Portugal (Asia and Europe Markets)
  • Sales Commence In H2 2020

     SUPERIOR MANAGEMENT TEAM

  • The InnoCan Leadership Group Is Incomparable In The Small Cap World
  • Comprised Of Leading Israeli Pharmaceutical Executives
  • Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
  • Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
  • Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
  • Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.
  • Together they have built a formidable team at InnoCan

SEEING IS BELIEVING

FULL DISCLOSURE: Innocan Pharma is an advertising client of AGORA Internet Relations Corp.

betterU $BTRU.ca Launches European Operations $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 9:56 AM on Monday, August 24th, 2020
  • betterU completes incorporation of betterU Europe Inc.
  • betterU launches Europe SaaS B2B platform

OTTAWA, ON / August 24, 2020 / betterU Education Corp. (TSX VENTURE:BTRU) (Frankfurt:5OGA) (the “Company” or “betterU”) is pleased to announce the successful launch of betterU Europe Inc. (BUI), a wholly-owned subsidiary of the Company, based in Dublin, Ireland. BUI has been established to facilitate and support a growing level of interest for online learning across European countries.

The e-learning market in Europe is poised to grow by $ 24.23 billion during 2020-2024 progressing at a CAGR of 12% during the forecast period. The market is driven by the availability of subject proficiency assessments and certifications and a rise in adoption of digital platform-enabled education.

BUI will also support several initiatives current under development including opportunities for non-dilutive investment and EU subsidies as well as several possible strategic partnerships. The Company has also recently launched https://betteruskills.com/en/ as part of its marketing efforts to support awareness and access to BUI services for European companies.

About betterU Education Corp.

betterU is an education-to-employment technology company offering an end-to-end solution leveraging business intelligence to automate skilling, reskilling and upskilling for companies operating on domestic and global scales. The Company supports the industry by providing them with everything an organization needs to launch and manage proper skills development programs so that they can focus on what really matters, their people!

Most companies spent too much time trying to source, integrate, customize and deliver fragmented skills development programs across their organization, when they should be focused solely on supporting their people. betterU’s integrated platform brings together the right technology, growing content library, customization, language options and is the most efficient affordable solution on the market. We don’t sell content, we help build better people.

For more information, please visit https://corporate.betteru.ca/corporate-gov/

Contact:

Brad Loiselle, CEO
1-613-695-4100
[email protected]

betterU Education Corp.
Investor Relations
Email: [email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Hollister Biosciences Inc. $HOLL.ca Reports Second Quarter 2020 Results With $8.47 Million In Revenue $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:25 AM on Monday, August 24th, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1

Multi-state operator and diversified cannabis branding company generates record quarterly revenue and delivers profitable second quarter

  • Revenue generated for the three-month period ended June 30th, 2020 was $8.47 million versus $0.2 million from the second quarter last year, representing significant year over year revenue growth
  • Revenue was primarily generated from the sale of concentrates, pre-rolls and contract manufacturing services

VANCOUVER, BC, Aug. 24, 2020 – Hollister Biosciences Inc. (CSE: HOLL), (OTC: HSTRF), (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, announces financial results for the second quarter 2020 (ended June 30th, 2020).  All figures in US Dollars unless otherwise stated.

Second Quarter Financial Highlights

  • Revenue generated for the three-month period ended June 30th, 2020 was $8.47 million versus $0.2 million from the second quarter last year, representing significant year over year revenue growth
  • Revenue was primarily generated from the sale of concentrates, pre-rolls and contract manufacturing services
  • Net income for the three-month period ended June 30th, 2020 was $0.3 million compared to a net loss of $2.1 million in the first quarter of 2020

“Our second quarter results are encouraging and in line with our objective to increase revenue and profitability” shared Alex Somjen, President of Hollister Biosciences Inc.  “These financial results are a product of increased brand awareness, strategic M&A and strategic partnerships put in place over the previous six months.”

Operational Highlights and Strategic Objectives for 2020

  • The challenges presented by the COVID-19 pandemic have accelerated Hollister’s plans to roll out direct to consumer delivery
    • The brand will be called “Dreamy Delivery” and the first delivery hub is expected to launch in the fourth quarter of 2020 with statewide delivery anticipated by the end of 2021
  • Design and build-out of Hollister’s 100% owned subsidiary, Venom Extracts, in the Company’s Hollister, CA facility are underway
  • Product development and product launch associated with the Company’s joint venture with Tactical Relief and the Company’s 100% owned subsidiary, Alpha Mind Brands Inc., respectively, are progressing
  • The Company’s partnership with Tommy Chong’s Cannabis is progressing well, with Tommy Chong’s Full Spectrum Elixir now being distributed in 20 dispensaries throughout the state of California by Hollister’s distribution partner Indus Holdings Inc. (CSE: INDS)

“Enormously proud of our teams in Arizona & California.  Our staff continues to overcome obstacles like the global pandemic while posting record revenue numbers. We look forward to continuing to execute on our plans while increasing value for our shareholders.” Said Carl Saling CEO of Hollister Biosciences.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website:www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-inc-reports-second-quarter-2020-results-301116831.html

SOURCE Hollister Biosciences Inc.

Esports Entertainment Group $GMBL to Present at The LD 500 Virtual Conference $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $TRWH

Posted by AGORACOM-JC at 8:20 AM on Monday, August 24th, 2020
  • Announced that its CEO Grant Johnson will be presenting at the LD 500 investor conference on Tuesday, September 1, 2020 at 9:20 a.m. EDT.
  • “We’ve achieved multiple key milestones since our listing on NASDAQ in April, and I look forward to sharing with the LD conference attendees more about these successes and what it means for the future of the Esports Entertainment Group,” commented Grant Johnson, CEO.

BIRKIRKARA, MALTA / August 24, 2020 / Esports Entertainment Group, Inc. (NASDAQ:GMBL)(NASDAQ:GMBLW) ( the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, today announced that its CEO Grant Johnson will be presenting at the LD 500 investor conference on Tuesday, September 1, 2020 at 9:20 a.m. EDT.

“We’ve achieved multiple key milestones since our listing on NASDAQ in April, and I look forward to sharing with the LD conference attendees more about these successes and what it means for the future of the Esports Entertainment Group,” commented Grant Johnson, CEO.

Register here: https://ld500.ldmicro.com/

“We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space.” stated Chris Lahiji, Founder of LD.

The LD 500 will take place on September 1st through the 4th.

View Esports Entertainment Group’s profile here: http://www.ldmicro.com/profile/GMBL

About Esports Entertainment Group

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fixed odds wagering, fantasy and pools on various esports events in a licensed, regulated and secure platform at vie.gg and owns and operates online sports book, SportNation.bet. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in the UK, Ireland, Malta and Curacao. The Company maintains offices in New Jersey, the UK and Malta. For more information visit www.esportsentertainmentgroup.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

SOURCE: Esports Entertainment Group, Inc.

Avicanna $AVCN.ca Advances its Supply Chain Business with Commercial Exports of #CBG And #CBD into the United States and Germany as well as Industrial Scale #THC Quota Granted by the Colombian Authorities $KHRN.ca $TRUL.ca $VFF.ca

Posted by AGORACOM-JC at 8:17 AM on Monday, August 24th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • The export of the CBG isolates into the United States is part of the first known industrial cultivation, extraction, and purification of cannabigerol (“CBG”) in Colombia, validating the Company’s early mover advantage in proprietary genetics, extraction, and high margin input materials.
  • The commercial THC cultivation quota for 11,587 psychoactive plants will be used for commercial production of THC derivatives for exports.
  • The group of exports into the United States were also piloted as a part of a global tracking system through StrainSecure™, a brand of TruTrace Technologies.

TORONTO, Aug. 24, 2020 – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that through its majority owned subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH“), the company has completed exports of CBG and CBD isolates into the United States, CBD isolate into Germany and the commencement of a pilot tracking system for the export of its active pharmaceutical ingredient (“API“) products in partnership with TruTrace Technologies Inc. (“TruTrace“) (CSE: TTT) (OTCQB: TTTSF). The Company is also pleased to announce that the Colombian Ministry of Justice and Law has granted SMGH a commercial and industrial cultivation quota for 12,264 THC plants by.

The export and sale of the commercial lot of isolated CBG into the United States was completed in parallel with commercial export of isolated CBD into the United States, as well as a pilot export for R&D purposes of CBD into Germany. The cultivation, extraction and purification of these cannabinoids including the rare cannabinoid, CBG, were all completed through Avicanna’s vertical integration at SMGH and validate the company’s innovation and leadership in natural rare cannabinoid production. The products are part of the Aureus™ product portfolio that now includes feminized seeds and advanced formulations as well as CBD, CBG and THC API products.

“This is another massive accomplishment for our team in Colombia as we enter the largest market in the world for non-psychoactive cannabinoids with our proprietary CBG offering. As the cannabinoid-derived products sector continues to evolve, our Aureus branded portfolio continues to advance in order to cater to the needs of our cosmetics and pharmaceutical partners, which require an innovative, credible, thoroughly-tested, organic, sustainable and economical source of input materials. Additionally, with the support of TruTrace, the Aureus products will be provided with traceability and trackability all the way back to the seed through a secured blockchain system.” – Aras Azadian, Chief Executive Officer of Avicanna.

The Colombian Ministry of Justice and Law granted SMGH a supplementary cultivation quota to cultivate 12,264 psychoactive cannabis plants. 11,587 plants will be destined to produce dry flower which will then be used to manufacture psychoactive derivatives for commercial production for export. The remaining 677 plants will be utilized for psychoactive derivatives for the purposes of research and development and pilot production of Avicanna’s RHO Phyto™ branded products in Colombia.

Lucas Nosiglia, President of Avicanna LATAM commented: “This achievement took years of characterization, evaluation and planning which will finally allow Avicanna to produce our THC products and export THC derivatives to our international partners. As one of the only companies permitted to produce THC commercially for the global market, we can focus on less competitive and high margin products.”

To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.

About StrainSecure™ by TruTrace

Designed specifically by TruTrace for the cannabis industry, StrainSecure™ is a fully integrated software platform, secured on blockchain which aggregates and authenticates all testing and quality assurance data on products and verifies the quality of each batch and lot in distribution. Furthermore, this deployment will mark the first utilization by TruTrace of the OrionOne™ global freight and logistics solution in the cannabis sector thereby providing dynamic visibility of verified Aureus products through the entire international shipping process.

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of SMGH to continue to complete exports of CBD and CBG isolates to the United States and Germany, SMGH’s ability to continue selling CBD and CBG isolates in the United States and Germany, SMGH’s ability to make use of the supplementary cultivation quota granted by the Colombian Ministry of Justice and Law, the ability of the Company to produce THC products using API produced by SMGH, and the ability of SMGH to export THC derivatives internationally. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

University of Pittsburgh Joseph M. Katz Graduate School of Business Selects ImagineAR $IP.ca $IPNFF as Partner in New MBA Course $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:19 AM on Monday, August 24th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced the Joseph M. Katz Graduate School of Business at the University of Pittsburgh is unveiling a new and exciting business disruption series course called, “Augmented and Virtual Reality (AR/VR) for Brands and Strategy.”
  • The course, in partnership with ImagineAR will be taught by Vanitha Swaminathan, Thomas Marshall Professor of Marketing. “Augmented and Virtual Reality for Brands and Strategy” will be initially available for MBA and MS students and eventually to undergraduate students at the College of Business Administration

VANCOUVER, BC and ERIE, PA, Aug. 24, 2020 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, retailers and brands to create their own instant mobile phone AR campaigns,  is pleased to announce the Joseph M. Katz Graduate School of Business at the University of Pittsburgh is unveiling a new and exciting business disruption series course called, “Augmented and Virtual Reality (AR/VR) for Brands and Strategy.”

The course, in partnership with ImagineAR will be taught by Vanitha Swaminathan, Thomas Marshall Professor of Marketing. “Augmented and Virtual Reality for Brands and Strategy” will be initially available for MBA and MS students and eventually to undergraduate students at the College of Business Administration. The entirety of the course will be taught in an online format.  U.S. News & World Report has ranked the Katz Graduate School of Business 39th in its 2021 ranking of the Best Business Schools in the United States.

During the span of the course, students will work in teams to identify how to apply augmented and virtual reality to a real business or company and to design a branding campaign. To conclude the course, students will present a 10-minute video showcasing their ideas.

“We’re thrilled to introduce the new series of business disruption courses,” said Sara Moeller, Associate Dean for Graduate Programs. “Augmented and Virtual Reality for Brands and Strategy, the inaugural course, is the first step in many new and exciting game-changing courses to come.”

AR/VR technologies have the potential to have a transformational role in how students learn, how managers make decisions and how consumers interact with products and branded experiences. Every business today is required to have an augmented reality strategy in order to unlock creative potential inherent in various touchpoints and user interfaces. 

“The offering of this course is extremely unique and timely,” said Swaminathan. “The current health crisis has required marketers to be even more creative in how to engage fans and customers. Augmented and virtual reality tools will provide new, creative ways of engaging with customers during this challenging period of social distancing.”

Alen Paul Silverrstieen, CEO & President of Imagine AR stated, “The adoption of the AR/VR course by the esteemed Joseph M. Katz Graduate School of Business is a real testament to ImagineAR.  The school has identified ImagineAR as an industry leader and AR as an enormous opportunity for brands to engage customers during these times where traditional methods would not suffice. I look forward to working with Professor Swaminathan on this revolutionary course work.”

The course will tie into a new case competition, Katz Augmented Reality Case Competition (ARCC), co-sponsored by the Center for Branding, Katz Marketing Club, Katz Technology Club, and ImagineAR. Katz graduate students will compete in teams of four to showcase their futuristic and creative ideas for how products and brands can become more innovative in the future. The Katz ARCC will provide an important way for students to gain exposure to AR/VR technologies and will challenge them to think through the various ways in which it can improve the brand experience.

To learn more about the Augmented and Virtual Reality for Brands and Strategy course, click this link.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR Inc. management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. 

SOURCE ImagineAR

St-Georges Eco-Mining $SX $SX.ca $SXOOF Beyond The AGM

Posted by AGORACOM-JC at 10:59 AM on Sunday, August 23rd, 2020

Beyond The AGM – St-George Eco-Mining, Segment 1 – Iceland

St-Georges Eco-Mining President and CEO, Vilhjalmur T. Vilhjalmsson and Dr Helen Salmon, one of the most knowledgeable academics that has specialised in Iceland Geology, discuss the state of mineral exploration in Iceland. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A


Beyond The AGM – St-George Eco-Mining, Segment 2 – Lithium Processing Tech

St-Georges Eco-Mining President and CEO, Vilhjalmur T. Vilhjalmsson and Enrico Di Cesare, President and CEO of St-Georges Metallurgy (A subsidiary of SX specialised in R&D) discuss the Company’s Lithium Processing Technology *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

Beyond The AGM – St-George Eco-Mining, Segment 3 – Canadian Resource Assets

Frank Dumas, COO & Director of St-Georges Eco-Mining, discusses the status of the Company’s Canadian exploration assets, including Julie and Manicouagan. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

—-

Beyond The AGM – St-George Eco-Mining, Segment 4 – Borealis

Frank Dumas, COO & Director of St-Georges Eco-Mining, discusses the status of Borealis, a Distributed and Decentralised Digital Derivative marketplace that is currently 100% owned by St-Georges and is located in Iceland. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

Beyond The AGM – St-George Eco-Mining, Segment 5 – Management Discussion

St-Georges Eco-Mining President and CEO, Vilhjalmur T. Vilhjalmsson and Frank Dumas, COO & Director of St-Georges Eco-Mining, discuss the overall status of the Company, it’s recovery from August 2018 and bright future looking forward. *Includes answers to questions posted by St-Georges shareholders on AGORACOM Q&A

Kings of The North Redux – St-Georges Eco-Mining $SX $SX.ca $SXOOF

Posted by AGORACOM-JC at 4:35 PM on Friday, August 21st, 2020
  • Announced that the Company has entered into a conditional binding agreement with BWA Group Plc of London to acquire all the outstanding shares of King of the North (KOTN), sold by St-Georges to BWA in September 2019
  • At the time of the transaction in 2019, St-Georges held 50.18% of KOTN
  • The proposed transaction with BWA and subsequently with the third-party arm-length other holders of the BWA securities will make St-Georges 100% owners of KOTN, that will be, once again, a wholly-owned subsidiary

Montreal – August 21, 2020 St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) announces that the Company has entered into a conditional binding agreement with BWA Group Plc of London to acquire all the outstanding shares of King of the North (KOTN), sold by St-Georges to BWA in September 2019.

At the time of the transaction in 2019, St-Georges held 50.18% of KOTN. The proposed transaction with BWA and subsequently with the third-party arm-length other holders of the BWA securities will make St-Georges 100% owners of KOTN, that will be, once again, a wholly-owned subsidiary.

KOTN was acquired from St-Georges and other related parties by BWA in October 2019 for a consideration of GBP4.66 million. Unfortunately, primarily arising from the impact of the COVID-19 restrictions, it has proved impossible to manage and effectively develop the investment in KOTN from the UK.

As a result, it has been agreed between the parties that St-Georges and the related parties to the original transaction will acquire the BWA’s 100 percent interest in KOTN by means of the cancellation of unconverted elements of the Convertible Unsecured Loan Notes issued as the original purchase consideration, amounting to a total of GBP4.3 million, of which GBP2,281,580 is coming from St-Georges. In addition, St-Georges will issue 1,500,000 common shares in favor of BWA. These shares will be subject to a standard 4 months regulatory hold. After closing the transaction, St-Georges is expected to retain its equity interest in BWA, amounting to approximately 21%.

The transaction is conditional to St-Georges and BWA’s ability to enter into a separate agreement with the related third parties that were part of the 2019 transaction.

The parties expect this transaction will be completed by August 31, 2020. Further information will be disclosed in the coming weeks.

Vilhjalmur Thor Vilhjalmsson, President and CEO of St-Georges, commented, “(…) It is unfortunate that BWA Group has been restricted in its efforts to develop these assets due to the impact of the pandemic on their operations. (…) We wish them all the best in the new direction they are taking, and we will be a supportive shareholder in their future successes (…) we will review the strategy and work program of these assets and divulge our intentions in a follow-up press release in the coming days(…).

The Company expects to disseminate a press release pertaining to its surface work campaign on the Iceland Thor Gold Project before common share transactions resume on the CSE.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur T. Vilhjalmsson”

VILHJALMUR THOR VILHJALMSSON


President & CEO

About St-Georges Eco-Mining Corp.

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry. The Company controls all the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & the Manicouagan Palladium Project on Quebec’s North Shore. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

#Apple $AAPL quietly acquired Israel’s #Camerai, formerly #Tipit, a specialist in #AR and camera tech SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 9:12 AM on Friday, August 21st, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Apple quietly acquired Israel’s Camerai, formerly Tipit, a specialist in AR and camera tech

  • Apple is well known for picking up smaller startups on the hush-hush to augment its business, and today news leaked out about the latest of these… nearly two years after the fact
  • Sometime between 2018 and 2019, the iPhone giant reportedly acquired and shut down Camerai, an augmented reality and computer vision company based out of Israel, which used to be called Tipit.
  • Calcalist said that the startup sold for several tens of millions of dollars.
  • From being founded in 2015, Camerai had raised around $5 million — including a $2.5 million round in 2017 and another unreported $2.5 million in 2018 — with investors including the Atooro Fund and another called the SKO Fund.

By: Ingrid Lunden

Apple is well known for picking up smaller startups on the hush-hush to augment its business, and today news leaked out about the latest of these… nearly two years after the fact. Sometime between 2018 and 2019, the iPhone giant reportedly acquired and shut down Camerai, an augmented reality and computer vision company based out of Israel, which used to be called Tipit.

The news was first reported earlier today by Israeli newspaper Calcalist, and we have reached out to ask Apple directly about it. In the meantime, Jonathan (Yehonatan) Rimon, who had been Camerai’s CEO and co-founded the company with Moty Kosharovsky, Erez Tal and Aaron Wetzler, declined to comment one way or the other on the report when we contacted him directly about it. A separate source confirmed the story to us. We’ll update as we learn more.

Calcalist said that the startup sold for several tens of millions of dollars. From being founded in 2015, Camerai had raised around $5 million — including a $2.5 million round in 2017 and another unreported $2.5 million in 2018 — with investors including the Atooro Fund and another called the SKO Fund.

It seems that the acquisition came on the heels of multiple approaches from a number of companies at a time when AR was arguably at a peak of hype and many big tech companies wanted a piece of the action. (Recall that 2018 was the year when Magic Leap raised nearly $1 billion in a single round of funding.) Back in 2018, we heard rumors that those approaching and looking at the startup included Apple, Samsung and Alibaba.

The Calcalist report said that Camerai employees joined Apple’s computer vision team, and that the company’s technology has been incorporated into Apple products already. It’s not clear specifically where and when, but recall that both iOS 13 and iOS 14 have featured big software updates to the camera.

Camerai had built an SDK and specifically a range of software-based AR tools to help edit and use camera-made images in more sophisticated ways,

Its tech included the ability to detect different objects in the picture, and outline them with precision to alter them cosmetically; the ability to outline and apply filters across the whole image; a “skeleton tracking” neural network API that could detect and draw body joints in real time overlaid on a picture of a human; and its own version of selective focus for enhanced portrait modes (remember this was 2018 and this was not standard on phones at the time). Camerai’s site is shut down, but here are some screenshots of how it all looked, pulled from the Internet Archive:

Camerai’s acquisition underscores a couple of interesting, and ongoing, trends.

The first of these is in the development of smartphone technology, particularly around cameras. Some of the more interesting innovations in smartphone camera technology have come not out of improvements in hardware, but software, where the application of breakthroughs in artificial intelligence can mean that an existing combination of sensor, lens and on-phone and cloud processors produce a better and more technically dynamic picture than before.

At a time when smartphone replacement cycles have really slowed down and we are seeing also slower innovation on hardware, bolting on talent and tech created outside the phone companies is one way to gain a competitive edge.

(Separately, I wonder if making cutting-edge technology software-based also means that there could be scope in the future for paid updates to older phone models, which could mean more incremental revenues from consumers that don’t want to invest incompletely new devices.)

The second trend that this deal underscores is how Israel remains fertile ground for bigger companies on the hunt to pick up and bolt on technology, and that the secretive approach is likely to remain for some time to come.

“In Israel there are over 350 global corporate companies, from 30 countries, who search for local innovation. Some of them like Apple, MS, Google, even have local R&D [operations],” said Avihai Michaeli, a Tel Aviv-based senior investment banker and startup advisor. “Those global companies look mainly for tech which could serve as its competitive edge. It is not the first time that an acquired startup is asked not to publish it was acquired, nor talk about it.”

Other acquisitions that Apple has made in Israel have included camera module maker LinX, semiconductor startup Anobit and 3D sensor company PrimeSense.

We’ll update this post as we learn more.

Source: https://techcrunch.com/2020/08/20/report-apple-quietly-acquired-israels-camerai-formerly-tipit-a-specialist-in-ar-and-camera-tech/